Drugs / Pneumococcal Conjugate Vaccine 13 (PCV13)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01527591 | Feb 2012 → Dec 2023 overdue | disease related to solid organ transplantation | University of California, Los Angeles | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pneumococcal Conjugate Vaccine 13 (PCV13) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01527591 ↗ |
| Modality | Vaccine | “13-valent pneumococcal conjugate vaccine” NCT01527591 ↗ |
| Route | Intramuscular | “A single intramuscular dose of 0.5 mL.” NCT01527591 ↗ |